货号:A255246
同义名:
2-Amino-2-norbornanecarboxylic acid; LAT1-IN-1
BCH (2-Amino-2-norbornanecarboxylic acid) 是L-型氨基酸转运体1(LAT1)的选择性竞争性抑制剂。它显著抑制细胞氨基酸摄取和mTOR磷酸化,从而抑制癌细胞生长并诱导凋亡。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | L-Type amino acid transporter 1 (LAT1) is overexpressed in malignant tumor cells to support their growth and proliferation. BCH is a LAT1 inhibitor that inhibits the uptake of [14C]L-leucine (1μM) in KB, Saos2, and C6 cells with IC50 values of 75.3±6.7μM, 78.8±3.5μM, and 73.1±4.5μM, respectively. BCH also exhibited anti-proliferative effects on KB, Saos2, and C6 cells with IC50 values of 6.9±0.4mM, 5.6±0.7mM, and 6.5 ± 0.9mM, respectively. Treatment of cancer cells with 20 mM BCH significantly increased the proportion of TUNEL-positive cells in comparison to the untreated groups. BCH treatment also significantly promoted proteolytic cleavage of procaspase-7 and procaspase-3 in cancer cells.[1] Treatment of primary mouse hepatocytes with 10mM BCH led to 38% and 50% increase in cellular and extracellular levels of glutamate, respectively. In normal C57BL/6J mice, treatment with 0.7g/kg BCH for 6 hr significantly increased glutamate level, glutamate dehydrogenase activity, and NAD+/NADH ratio in the liver. In mice fed with high fat/high fructose western diet, peritoneal injection of BCH (0.7g/kg/day) for 8 weeks reduced the level of triglyceride by 30% compared to the control group. BCH treatment also reduced high fat/high fructose diet-induced stress, inflammation and ameliorated hepatic injury and hyperglycemia in mice.[2] |
| 作用机制 | BCH is a selective LAT1 inhibitor that can suppress cell growth and induce apoptosis.[1] |
| Concentration | Treated Time | Description | References | |
| Human breast adenocarcinoma cells (MCF-7) | 100 µM | 72 h | Assess apoptosis and cytotoxicity. Results showed that compound 1 significantly reduced the percentage of viable cells and induced apoptosis. | Apoptosis. 2020 Jun;25(5-6):426-440. |
| Human aortic smooth muscle cells (AoSMC) | 1-100 µM | 24 h | Assess cell viability and morphological changes. Results showed that at concentrations below 50 µM, compound 1 had minimal effects on AoSMC viability. | Apoptosis. 2020 Jun;25(5-6):426-440. |
| Human umbilical vein endothelial cells (HUVEC) | 1-100 µM | 24 h | Assess cell viability and morphological changes. Results showed that at concentrations below 10 µM, compound 1 had minimal effects on HUVEC viability. | Apoptosis. 2020 Jun;25(5-6):426-440. |
| African green monkey kidney fibroblast-like cells (COS1 cells) | 1 mM | Inhibited LAT1 and LAT2 activity | Thyroid. 2022 Sep;32(9):1129-1137. | |
| organotypic forebrain slice culture model | 10 mM | 24 h | To study the effect of SLC7A5/SLC3A2 inhibition on BCAA transport, results showed BCH had little effect on metabolite abundance | Sci Rep. 2021 Apr 27;11(1):9092. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
6.44mL 1.29mL 0.64mL |
32.22mL 6.44mL 3.22mL |
64.44mL 12.89mL 6.44mL |
|
| CAS号 | 20448-79-7 |
| 分子式 | C8H13NO2 |
| 分子量 | 155.19 |
| SMILES Code | NC1(C(O)=O)CC2CCC1C2 |
| MDL No. | MFCD00167580 |
| 别名 | 2-Amino-2-norbornanecarboxylic acid; LAT1-IN-1 |
| 运输 | 蓝冰 |
| InChI Key | MPUVBVXDFRDIPT-UHFFFAOYSA-N |
| Pubchem ID | 115288 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
H2O: 20 mg/mL(128.87 mM),配合低频超声,并水浴加热至45℃助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1